Abstract:Background: It is well established that individuals with schizophrenia experience deficits in emotional perception that can impact long-term social and occupational functioning. Understanding the factors that impact these impairments is important for targeting interventions to improve recovery. In the general population, compared with males, females tend to show greater perception of emotions. Whether this sex difference persists in schizophrenia is less clear. In contrast to males, females diagnosed with schizophrenia tend to have a higher age of disease onset and better premorbid functioning but do not necessarily have better outcomes. Effective treatments for social cognitive impairments are highly relevant to long-term functional rehabilitation. A greater understanding of the cognitive deficits in emotional perception within females and males living with schizophrenia may assist interventions to be better tailored to individuals. Objective: This systematic review aims to collate, synthesize, and critically appraise evidence considering the influence of biological sex (female and male) on the emotional perception of individuals with schizophrenia. Methods: This is a systematic review protocol based on the PRISMA-P (Preferred Reporting Items for Systematic Reviews and Meta-Analyses Protocols) guidelines. The electronic databases MEDLINE, Embase, CENTRAL, CINAHL, and PsycINFO will be systematically searched. To be included in this review, studies must compare the emotional perceptions of male and female participants older than 18 years who have a primary diagnosis of a schizophrenia spectrum disorder. Qualitative studies, case reports, case series, unpublished manuscripts, and studies not reported in English will be excluded. Key search strategies will include combinations of the following terms: "men," "male," "man," "female," "women," "woman," "sex," "gender," "emotional perception," "emotional processing," "schizophrenia," "schizophren," "psychotic disorders," "psychosis," "psychoses," "psychotic," "schizoaffective," "schizotypal personality disorder," and "schizotyp." Identified studies will be uploaded to the web-based Covidence systematic review management software. The risk of bias for individual studies will be assessed using the relevant Joanna Briggs Institute checklist tools. The GRADE (Grading of Recommendations Assessment, Development, and Evaluation) system will also be used to evaluate the strength of the evidence base. Findings will be synthesized to provide a systematic summary of the existing literature. If sufficiently comparable data to permit meta-analysis emerges, a random-effects meta-analysis will be performed. Results: This systematic review was registered with the PROSPERO (International Prospective Register of Systematic Reviews) in October 2023. The search and screening of study titles and abstracts are currently underway. Data are expected to be extracted and analyzed in July 2024. Conclusions: Results will contribute to an improved understanding of the social cognitive profiles of males and females with schizophrenia. This knowledge is expected to inform the adaptation of interventions to improve functional outcomes. Trial registration: PROSPERO CRD42023463561; https://tinyurl.com/34sr3rnf. International registered report identifier (irrid): DERR1-10.2196/56977.

Sex versus gender associations with depressive symptom trajectories over 24 months in first-episode schizophrenia spectrum disorders

Gender Differences of Schizophrenia Patients with and Without Depressive Symptoms in Clinical Characteristics.

Gender differences in first episode psychosis: Some arguments to develop gender specific treatment strategies

Sex differences in association between cognitive impairment and clinical correlates in Chinese patients with first-episode drug-naïve schizophrenia

Gender Differences of Neurocognitive Functioning in Patients with First-Episode Schizophrenia in China.

Gender Differences in Never-Medicated First-Episode Schizophrenia and Medicated Chronic Schizophrenia Patients.

Male Sex May Be Associated with Higher Metabolic Risk in First-Episode Schizophrenia Patients: A Preliminary Study

Sex Differences in Residual Somatic Symptoms in Patients with First-Episode Depression after Acute-Phase Treatment

Gender differences in cognitive improvements after two months of atypical antipsychotic treatment in first episode schizophrenia

Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients

Depressive Symptoms Evaluated by the Calgary Depression Scale for Schizophrenia (CDSS): Genetic Vulnerability and Sex Effects

Sex Differences in the Association Between Symptom Profiles and Cognitive Functioning in Patients with Depressive Disorder

Sex differences in diagnostic stability in first episode psychosis after 1-year follow-up

Sex-specific associations between sex hormones and clinical symptoms in late-life schizophrenia

Anxious-depressive symptoms after a first episode of schizophrenia: Response to treatment and psychopathological considerations from a 2-year follow-up study in Italy

Sex Differences in Pharmacotherapy of Schizophrenia:Findings from National Survey 2012 on Use of Psychotropic Medications

How do men and women differ in their depressive symptomatology? A gendered network analysis of depressive symptoms in a French population-based cohort

Impact of Biological Sex on Emotional Perception Among Adults With Schizophrenia Spectrum Disorders: Protocol for a Systematic Review

Sex differences in clinical presentation in youth at high risk for psychosis who transition to psychosis

Sex matters: Differences in prodromes, clinical and neuropsychological features in individuals with a first episode mania or psychosis

Gender Differences in Prevalence and Associated Factors of Metabolic Syndrome in First-Treatment and Drug-Naïve Schizophrenia Patients.